Skip to main content
Premium Trial:

Request an Annual Quote

Page Joins Chronic Disease Startup

Andy Page, the former president of 23andMe, has joined Livongo, a chronic disease-focused startup, CNBC reports.

Livongo in particular aims to help patients with diabetes manage their condition. According to CNBC, the company provides patients with blood glucose monitors and testing strips. When they have a result that's outside the normal range, a Livongo coach steps in to offer to feedback and if that doesn't work, a specialist is then brought in, it adds. "The idea is to reduce strain on the healthcare system," Page tells CNBC.

Page left 23andMe last November. While there, he oversaw the firm's product and engineering, marketing, laboratory operations, and legal and regulatory affairs, among other areas.

CNBC adds that Glen Tullman, the former CEO of Allscripts, a health information technology company, started Livongo in 2014.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.